These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4777608

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative study of the urinary excretion of nitrofurantoin in man, administered in the form of macro-or microcrystals].
    Forn J, Pino MT.
    Rev Clin Esp; 1974 Apr 30; 133(2):155-8. PubMed ID: 4844770
    [No Abstract] [Full Text] [Related]

  • 23. Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
    Bates TR, Rosenberg HA, Tembo AV.
    J Pharm Sci; 1973 Dec 30; 62(12):2057-8. PubMed ID: 4762187
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets, and capsules.
    Bates TR, Young JM, Wu CM, Rosenberg HA.
    J Pharm Sci; 1974 Apr 30; 63(4):643-5. PubMed ID: 4828728
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.
    Ertan G, Karasulu E, Abou-Nada M, Tosun M, Ozer A.
    J Microencapsul; 1994 Apr 30; 11(2):137-40. PubMed ID: 8006760
    [Abstract] [Full Text] [Related]

  • 28. [ABSORPTION OF NITROFURANTOIN IN DIFFERENT PHARMACEUTICAL FORMS. RELATION BETWEEN THE IN VITRO DISINTEGRATION TIME AND THE ABSORPTION OF THE DRUG BY ORAL ROUTE].
    FORN X, VERA A, PINO MT, MATEU J.
    Med Clin (Barc); 1964 May 30; 42():373-7. PubMed ID: 14202356
    [No Abstract] [Full Text] [Related]

  • 29. Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man.
    Bron J, Vree TB, Damsma JE, Hekster YA, van der Kleijn E.
    Arzneimittelforschung; 1979 May 30; 29(10):1614-20. PubMed ID: 42416
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
    Corrigan OI, Timoney RF.
    Ir J Med Sci; 1974 Jul 30; 143(4):197-207. PubMed ID: 4605123
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Macrodantin v. standard nitrofurantoin.
    Drug Ther Bull; 1974 Jun 07; 12(12):47-8. PubMed ID: 4457295
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.